MIRA•benzinga•
EXCLUSIVE: MIRA Pharmaceuticals Tells Benzinga Co's Board Of Directors Approve SKNY Pharmaceuticals Acquisition Following Independent Valuation, Says Combined Enterprise Value Exceeding $60M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga